Analyzing...
In continuation of our letter dated 15th July, 2024 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the transcript of the conference call held on 26th July, 2024, on the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th June, 2024, is available on the Company’s website at https://www.piramalpharma.com/financial-reports Kindly take the above on record. Thanking you,